ACS medicinal chemistry letters, 2017-09, Vol.8 (9), p.987-987
- Sandham, David A
- Barker, Lucy
- Brown, Lyndon
- Brown, Zarin
- Budd, David
- Charlton, Steven J
- Chatterjee, Devnandan
- Cox, Brian
- Dubois, Gerald
- Duggan, Nicholas
- Hall, Edward
- Hatto, Julia
- Maas, Janet
- Manini, Jodie
- Profit, Rachael
- Riddy, Darren
- Ritchie, Catherine
- Sohal, Bindi
- Shaw, Duncan
- Stringer, Rowan
- Sykes, David A
- Thomas, Matthew
- Turner, Katharine L
- Watson, Simon J
- West, Ryan
- Willard, Elisabeth
- Williams, Gareth
- Willis, Jennifer
2017
Details
- Autor(en) / Beteiligte
- Sandham, David A
- Barker, Lucy
- Brown, Lyndon
- Brown, Zarin
- Budd, David
- Charlton, Steven J
- Chatterjee, Devnandan
- Cox, Brian
- Dubois, Gerald
- Duggan, Nicholas
- Hall, Edward
- Hatto, Julia
- Maas, Janet
- Manini, Jodie
- Profit, Rachael
- Riddy, Darren
- Ritchie, Catherine
- Sohal, Bindi
- Shaw, Duncan
- Stringer, Rowan
- Sykes, David A
- Thomas, Matthew
- Turner, Katharine L
- Watson, Simon J
- West, Ryan
- Willard, Elisabeth
- Williams, Gareth
- Willis, Jennifer
- Titel
- Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma”
- Ist Teil von
- ACS medicinal chemistry letters, 2017-09, Vol.8 (9), p.987-987
- Ort / Verlag
- American Chemical Society
- Erscheinungsjahr
- 2017
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1948-5875eISSN: 1948-5875DOI: 10.1021/acsmedchemlett.7b00353Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5601380
- Format
- –